4//SEC Filing
Clarus Lifesciences III, L.P. 4
Accession 0000899243-21-019575
CIK 0001689548other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:46 PM ET
Size
10.5 KB
Accession
0000899243-21-019575
Insider Transaction Report
Form 4
Clarus Lifesciences III, L.P.
10% Owner
Transactions
- Other
Common Stock
2021-05-12−2,700,000→ 4,894,109 total(indirect: See Footnotes)
Holdings
- 907,378(indirect: See Footnotes)
Common Stock
Footnotes (6)
- [F1]Reflects a pro rata distribution to the partners of Clarus Lifesciences III, L.P., including 956,098 of which were distributed to Clarus Ventures III GP, L.P., its general partner, which distributed such 956,098 shares to its partners.
- [F2]Reflects securities held directly by Clarus Lifesciences III, L.P. Clarus Ventures III GP, L.P. is the general partner of Clarus Lifesciences III, L.P. Blackstone Clarus III L.L.C. is the general partner of Clarus Ventures III GP, L.P. The sole member of Blackstone Clarus III L.L.C. is Blackstone Holdings II L.P.
- [F3]Reflects securities held directly by BSOF Parallel Master Fund L.P. Blackstone Strategic Opportunity Associates L.L.C. is the general partner of BSOF Parallel Master Fund L.P. Blackstone Holdings II L.P. is the sole member of Blackstone Strategic Opportunity Associates L.L.C. Blackstone Alternative Solutions L.L.C. is the investment manager of BSOF Parallel Master Fund L.P. Blackstone Holdings I L.P. is the sole member of Blackstone Alternative Solutions L.L.C.
- [F4]The general partner of each of Blackstone Holdings I L.P. and Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Series II preferred stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
- [F5]Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
- [F6]Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Praxis Precision Medicines, Inc.
CIK 0001689548
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001597143
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 9:46 PM ET
- Size
- 10.5 KB